Trademark: 88598286
Word
CELLREGEN
Status
Dead
Status Code
606
Status Date
Monday, October 25, 2021
Serial Number
88598286
Mark Type
3000
Filing Date
Thursday, August 29, 2019
Published for Opposition
Tuesday, January 26, 2021
Abandoned Date
Monday, October 25, 2021

Trademark Owner History

Classifications
1 Biological preparations for others, namely, human cells and tissue for scientific and research use; Cells and biological tissue, namely, human tissue, stem cells, bone marrow, amniotic fluid and blood, for scientific research and use in cellular therapies; biological preparations for others, namely, human cells and tissue, for use in the research of treatment of degenerative diseases, wound healing, and cell therapy
5 Biological and chemical products for use by clinicians in regenerative medicine for medical purposes, namely, cellular healing therapies and regenerative medicine
35 Business consulting and industry collaboration in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, applications for drug approval and product development; providing product commercialization assistance in the field of cellular therapy and regenerative medicine; commercialization services in the field of cellular therapy and regenerative medicine
40 Contract manufacturing, namely, manufacture of cellular therapies and regenerative medicines; conducting manufacturing support, namely, development of operating procedures and batch records, cell expansion, master and working cell bank production and clinical trials in the field of cellular therapy and regenerative medicine
41 Academic support, namely, providing clinical programs, academic conferences, training, mentoring and fellowships in the field of clinical trials, technology transfer, product development, optimization, manufacturing and commercialization; educational services in the field of cellular therapy and regenerative medicine
42 Conducting clinical trials and research for others in the field of cellular therapy and regenerative medicine; providing medical and scientific research information in the field of clinical trials for cellular therapy and regenerative medicine; Product research and development; Product development consultation; Product research and development services for others in the field of cellular therapy and regenerative medicine; scientific development in the field of stem cells and regenerative medicine; scientific research, discovery, technology transfer, process development and clinical trials in the field of cellular therapy and regenerative medicine
44 Medical services in the field of cell-based therapies, including the use of biological cells and tissue in the delivery of cell-based therapies and regenerative medicine; Cell therapy services for the treatment of degenerative diseases, wounds, hematologic diseases, hematologic disorders and immuno-therapy; providing consultancy and information relating to these cell therapies for medical purposes; administration of cell therapies for the treatment of disorders, diseases, and injuries; medical services, namely, isolation of regenerative cells relating to cell therapy services, stem cell collection, processing, phenotypic characterization, infusion and storage for medical and scientific purposes; providing medical therapies, namely, stem cell therapies and therapies for regeneration of human tissues and cells; providing educational medical information about cellular therapy and regenerative medicines
Color is not claimed as a feature of the mark.
The mark consists of The word "CellReGen" with the letters "C" "R" and "G" all capitalized, with the "R" having a gapped corner on the top left, all to the left of a square that has gapped corners on the top left and bottom right.
CELL REGEN

Trademark Events
Oct 25, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 25, 2021
Abandonment - No Use Statement Filed
Mar 23, 2021
Noa E-Mailed - Sou Required From Applicant
Jan 26, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 26, 2021
Published For Opposition
Jan 6, 2021
Notification Of Notice Of Publication E-Mailed
Dec 17, 2020
Approved For Pub - Principal Register
Dec 16, 2020
Teas/Email Correspondence Entered
Dec 15, 2020
Correspondence Received In Law Office
Dec 15, 2020
Teas Response To Office Action Received
Jun 24, 2020
Notification Of Non-Final Action E-Mailed
Jun 24, 2020
Non-Final Action E-Mailed
Jun 24, 2020
Non-Final Action Written
Jun 4, 2020
Teas/Email Correspondence Entered
Jun 4, 2020
Correspondence Received In Law Office
Jun 4, 2020
Teas Response To Office Action Received
Dec 4, 2019
Notification Of Non-Final Action E-Mailed
Dec 4, 2019
Non-Final Action E-Mailed
Dec 4, 2019
Non-Final Action Written
Dec 2, 2019
Assigned To Examiner
Sep 12, 2019
Notice Of Design Search Code E-Mailed
Sep 11, 2019
New Application Office Supplied Data Entered In Tram
Sep 2, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24